Trials / Completed
CompletedNCT00653549
Bioavailability Study of Torsemide Tablets Under Fasting Conditions
Comparative, Randomized, Single-Dose, 2 Way Cross Over Bioavailability Study of Par Torsemide Tablets 20mg With That of Roche Demadex 1*20 mg in Healthy Subjects Under Fasting Conditions.
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 26 (actual)
- Sponsor
- Par Pharmaceutical, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
To compare the single-dose bioavailability of Torsemide tablets with Demadex
Detailed description
To compare the single -dose bioavailability of Par Torsemide tablets 20mg with that Roche Demadex 1\*20mg tablets under fasting conditions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Torsemide | Tablets, 20 mg, single-dose |
| DRUG | Demadex | tablets, 20 mg, single-dose |
Timeline
- Start date
- 2001-04-01
- Primary completion
- 2001-05-01
- Completion
- 2001-05-01
- First posted
- 2008-04-07
- Last updated
- 2011-06-17
Source: ClinicalTrials.gov record NCT00653549. Inclusion in this directory is not an endorsement.